Cytokinetics Inc (CYTK) Company Report Oct. 10, 2022, 04:31 UTC 33 Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis Comment Full text
Mustang Bio Inc (MBIO) Company Report Oct. 06, 2022, 05:34 UTC 37 Mustang Bio Announces First Patient Treated in Its Multicenter Phase 1/2 Clinical Trial of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy to Treat B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Comment Full text
QuantumSi Inc (QSI) Company Report Oct. 04, 2022, 05:20 UTC 36 New Form 8-K for Quantum-Si Incorporated Comment Full text
QuantumSi Inc (QSI) Company Report Oct. 04, 2022, 05:02 UTC 34 Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer Comment Full text
Cytokinetics Inc (CYTK) Company Report Oct. 03, 2022, 13:01 UTC 37 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
Cytokinetics Inc (CYTK) Company Report Oct. 02, 2022, 06:46 UTC 34 Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting Comment Full text
Abcam Plc (ABCM) Company Report Sept. 30, 2022, 07:54 UTC 35 Abcam Plc Notification Comment Full text